10000|10000|Public
5|$|Another 12 {{universities}} has <b>been</b> <b>approved</b> by UGC recently but yet {{to start}} operation. So {{the total number}} of approved private university is now 92 (as of February 2016).|$|E
5|$|Colbert wrote The Magical Worlds of Harry Potter while {{teaching}} {{a seminar on}} self-publishing to graduate students at the University of North Carolina. He had it self-published in March 2001 and hired a company {{to take care of}} accounting, marketing, promotion, and selling. Colbert has never met Rowling and the book has not <b>been</b> <b>approved</b> by her or Warner Brothers (the owner of the film rights to the Harry Potter novels). He was given permission to publish it as long as he noted on the cover that it had not <b>been</b> <b>approved</b> by Rowling.|$|E
5|$|Military {{commissions}} {{are legitimate}} forums to try enemy combatants {{because they have}} <b>been</b> <b>approved</b> by Congress.|$|E
50|$|Avobenzone was {{patented}} in 1973 and <b>was</b> <b>approved</b> in the EU in 1978. It <b>was</b> <b>approved</b> by the FDA in 1988. Its use <b>is</b> <b>approved</b> worldwide.|$|R
50|$|It <b>was</b> <b>approved</b> in Canada in 1993 for the {{treatment}} of bladder cancer.It <b>was</b> <b>approved</b> in Japan in 1994 (for early stage lung cancer?).It <b>was</b> <b>approved</b> by the U.S. FDA in December 1995 for esophageal cancer, and in 1998, it <b>was</b> <b>approved</b> for {{the treatment}} of early non-small cell lung cancer.|$|R
50|$|Funding for {{the first}} series <b>was</b> <b>approved</b> by NZ On Air in December 2009, a second series <b>was</b> <b>approved</b> in June 2011 and a third series <b>was</b> <b>approved</b> on 15 October 2012.|$|R
5|$|On 24 October, the IMF {{tentatively}} {{agreed to}} lend €1.58 billion. However the loan had still not <b>been</b> <b>approved</b> by the Executive Board of the IMF on 13 November. Due to the delay Iceland found itself {{caught in a}} classic catch-22 situation, loans from other countries could not be secured until the IMF program had <b>been</b> <b>approved.</b> The Icelandic government spoke of a $500M (€376M) gap in the funding plans. Dutch finance minister Wouter Bos stated that the Netherlands would oppose the loan unless agreement was reached over deposit insurance for Landsbanki customers in the Netherlands.|$|E
5|$|The {{results of}} these {{clinical}} trials {{have not yet been}} disclosed and no SEGRAM has as yet <b>been</b> <b>approved</b> for clinical use.|$|E
5|$|As of 2017, eleven disease-modifying {{medications}} have <b>been</b> <b>approved</b> by {{regulatory agencies}} for relapsing-remitting multiple sclerosis (RRMS). They are interferon beta-1a, interferon beta-1b, glatiramer acetate, mitoxantrone, natalizumab, fingolimod, teriflunomide, dimethyl fumarate, alemtuzumab, daclizumab, and ocrelizumab.|$|E
25|$|It <b>is</b> <b>approved</b> in {{only one}} sub-Saharan African country—South Africa, where it <b>was</b> <b>approved</b> in 2001. It <b>is</b> also <b>approved</b> in one north African country—Tunisia, also in 2001.|$|R
50|$|Several {{antiretroviral}} drugs {{based on}} Holý's discoveries have been licensed. In 1996, Vistide <b>was</b> <b>approved</b> for {{production in the}} United States and European Union. Viread (tenofovir) <b>was</b> <b>approved</b> in the USA in 2001 {{for the treatment of}} AIDS, and Hepsera <b>was</b> <b>approved</b> in 2003 for the treatment of hepatitis B. Truvada, a combination of Viread and emtricitabine, <b>was</b> <b>approved</b> in 2006 for use in the USA.|$|R
50|$|Two {{measures}} <b>were</b> <b>approved</b> in the May 4 election. No ballot measures <b>were</b> <b>approved</b> for {{the general}} election.|$|R
5|$|As of 2017, several disease-modifying {{treatments}} have <b>been</b> <b>approved</b> by {{regulatory agencies}} of different countries, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMEA) and the Pharmaceuticals and Medical Devices Agency (PMDA) of the Japanese Ministry of Health, Labour and Welfare.|$|E
5|$|As of March 2012, the {{government}} announced that the P60 billion LRT-1 south extension project has already <b>been</b> <b>approved</b> by the National Economic and Development Authority (NEDA) with the bidding expected to take place {{by the end of}} March or early April 2012.|$|E
5|$|At {{both state}} and federal realms in Australia, assent is used as the means of {{enforcing}} a referendum that is required. This is done by providing {{that it will not}} be lawful to even submit the law for viceregal assent unless and until it has <b>been</b> <b>approved</b> by the required percentage of the voting populace at a referendum.|$|E
50|$|EDXL-DE <b>was</b> <b>approved</b> as an OASIS Standard in 2006; EDXL-RM and -HAVE <b>were</b> <b>approved</b> as OASIS Standards in 2008.|$|R
50|$|As of 2005, {{clobazam}} <b>is</b> <b>approved</b> in Canada for add-on use in tonic-clonic, complex partial, and myoclonic seizures. Clobazam <b>is</b> <b>approved</b> for adjunctive {{therapy in}} complex partial seizures {{certain types of}} status epilepticus, specifically the myoclonic, myoclonic-absent, simple partial, complex partial, and tonic varieties, and non-status absence seizures. It <b>is</b> also <b>approved</b> for treatment of anxiety.In India, clobazam <b>is</b> <b>approved</b> for use as an adjunctive therapy in epilepsy and in acute and chronic anxiety. In Japan, clobazam <b>is</b> <b>approved</b> for adjunctive therapy in treatment-resistant epilepsy featuring complex partial seizures. In New Zealand, clobazam is marketed as Frisium In the United Kingdom clobazam (Frisium) <b>is</b> <b>approved</b> for short-term (2-4 weeks) relief of acute anxiety in patients who have not responded to other drugs, with or without insomnia and without uncontrolled clinical depression. It <b>was</b> not <b>approved</b> in the US until October 25, 2011, when it <b>was</b> <b>approved</b> for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in patients 2 {{years of age or}} older.|$|R
50|$|Pembrolizumab {{is another}} PD1 {{inhibitor}} that <b>was</b> <b>approved</b> by the FDA in 2014. Keytruda (Pembrolizumab) <b>is</b> <b>approved</b> to treat melanoma and lung cancer.|$|R
5|$|Corzine {{spent some}} $200,000 {{of public funds}} on {{advertisements}} to promote {{a referendum on the}} 2007 New Jersey ballot to borrow $450million to fund stem cell research. The referendum faced strong opposition and was rejected despite the fact that $270million had previously <b>been</b> <b>approved</b> to build stem cell research centers.|$|E
5|$|Farran Zerbe, whose {{paper to}} the ANA {{convention}} helped launch the dollar proposal, saw de Francisci's defense and the press release, and suggested that the sculptor had mistakenly thought his alternate design had <b>been</b> <b>approved.</b>|$|E
5|$|In 2016 a {{partially}} effective vaccine for dengue fever became commercially {{available in the}} Philippines and Indonesia. It has also <b>been</b> <b>approved</b> for use by Mexico, Brazil, El Salvador, Costa Rica, and Paraguay. In Indonesia it costs about US$207 for the recommended three doses.|$|E
30|$|The {{validity}} of factors <b>was</b> <b>approved</b> by average variance extracted (AVE) Fornell and Larcker test. The {{validity of}} measures <b>was</b> <b>approved</b> by cross loadings.|$|R
50|$|It was {{the first}} {{selective}} estrogen receptor degrader to <b>be</b> <b>approved,</b> and <b>was</b> <b>approved</b> in the US in 2002 and in Europe in 2004.|$|R
50|$|Thiamethoxam <b>is</b> <b>approved</b> {{for use in}} the US as an {{antimicrobial}} pesticide {{wood preservative}} and as a pesticide; it <b>was</b> first <b>approved</b> in 1999. As of 2014, it <b>is</b> <b>approved</b> for use {{in a wide range of}} crops.|$|R
5|$|In October 2016, in an {{interview}} with NME, Armstrong revealed that the movie had <b>been</b> <b>approved</b> by HBO. At that point, the script was still getting rewrites; production date was not set officially but is aimed to begin in late 2017. Armstrong confirmed he would reprise his Broadway role as St. Jimmy.|$|E
5|$|In {{response}} to this, a nationwide lobbying effort was coordinated among astronomers. Many astronomers met congressmen and senators in person, and large scale letter-writing campaigns were organized. The National Academy of Sciences published a report emphasizing {{the need for}} a space telescope, and eventually the Senate agreed to half of the budget that had originally <b>been</b> <b>approved</b> by Congress.|$|E
5|$|Ipilimumab blocks {{signaling}} {{through a}} receptor on T cells known as CTLA-4 which dampens down the immune system. It has <b>been</b> <b>approved</b> by the U.S. Food and Drug Administration (FDA) {{for treatment of}} melanoma and is undergoing clinical trials for both {{non-small cell lung cancer}} (NSCLC) and small cell lung cancer (SCLC).|$|E
5000|$|The Bachelor of Science and Master of Science in Nursing {{programs}}, <b>are</b> <b>approved</b> by the California Board of Registered Nursing. The nursing {{programs at}} the Dallas campus <b>are</b> <b>approved</b> by the Texas Board of Nursing [...] and the nursing {{programs at the}} Miami campus <b>are</b> <b>approved</b> by the Florida Board of Nursing.|$|R
50|$|Prior to the referendums, the quorum {{required}} for a proposal to <b>be</b> <b>approved</b> <b>was</b> reduced from 32% to 25%, meaning that 8,398 voters had to vote in favour for the proposals to <b>be</b> <b>approved.</b>|$|R
50|$|Dexlansoprazole <b>was</b> <b>approved</b> by the U.S. Food and Drug Administration (FDA) in 2009, and <b>was</b> <b>approved</b> in Canada in 2010 and in Mexico in 2011.|$|R
5|$|On February 5, 2013, Colorado {{representative}} Jared Polis introduced Ending Federal Marijuana Prohibition Act of 2013 (H.R. 499; 113th Congress), a {{bill that}} would decriminalize marijuana on the federal level, instead treating it as a substance to be regulated in a similar manner to alcohol. The act has not <b>been</b> <b>approved</b> by Congress.|$|E
5|$|Planning {{permission}} has <b>been</b> <b>approved</b> for a 200-room five star Hilton hotel {{opposite the}} new Leeds Arena site which {{was due to}} be completed around 2015, although the project is currently on hiatus following {{the collapse of the}} main contractor involved. The development was relocated from Clarence Dock following the refusal of its planning permission for that site.|$|E
5|$|Recognised {{sports are}} sports which have <b>been</b> <b>approved</b> by the Commonwealth Games Federation but which are deemed to need expansion; host nations may not pick these sports for their {{programme}} until the Federation's requirements are fulfilled.|$|E
25|$|The {{design life}} is 15,000 hours, though at present it <b>is</b> <b>approved</b> for only 4,000 hours of operation. In 15m configuration, the SZD-59 <b>is</b> <b>approved</b> in the utility {{category}} of JAR 22 (sailplanes) of the Joint Aviation Authorities, {{and in the}} 13.2m configuration it <b>is</b> <b>approved</b> according to the aerobatics category of JAR 22.|$|R
50|$|It <b>was</b> {{initially}} <b>approved</b> in Europe in 2007 for schizophrenia, {{the extended}} release form and use for schizoaffective disorder <b>were</b> <b>approved</b> in Europe in 2010, and extension {{to use in}} adolescents older than 15 years old <b>was</b> <b>approved</b> in 2014.|$|R
25|$|The Catalan government's decree officially {{calling the}} {{referendum}} {{was expected to}} <b>be</b> <b>approved</b> {{in the second half}} of August but <b>was</b> <b>approved</b> only on 6 September.|$|R
